Cal-maine Foods Stock News

Cal-Maine Foods Keeps Rising

A rapidly escalating bird-flu outbreak in the U.S. is contributing to a surge in egg prices and threatens to raise prices on other poultry products in the coming months as deaths continue to mount.

Cal-Maine Foods (NASDAQ: CALM) struggled with profitability last year leading us to write the stock off at the end of 2021. That was a mistake because right about the time we were cutting the stock lo

Upgrades For Cal-Maine Foods Inc (NASDAQ:CALM), Consumer Edge Research upgraded the previous rating of Equal-Weight to Overweight. For the third quarter, Cal-Maine Foods had an EPS of $0.81, compared

RIDGELAND, Miss.--(BUSINESS WIRE)--Cal-Maine Foods, Inc. (NASDAQ: CALM) today announced that the Company will release its third quarter fiscal 2022 financial results on Tuesday, March 29, 2022. A pres

Cal-Maine Foods, Inc. (CALM) shares closed today at 1.1% below its 52 week high of $43.20, giving the company a market cap of $1B. The stock is currently up 15.2% year-to-date, up 7.5% over the past 12 months, and up 12.6% over the past five years. This week, the Dow Jones Industrial Average fell 1.7%, and the S&P 500 fell 1.4%. Trading Activity Trading volume this week was 27.4% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.1. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold.The stock closed at 0.3% higher than its 5-day moving average, 4.1% higher than its 20-day moving average, and 12.5% higher than its 90-day moving average. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Consumer Staples industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -1044.4% The company's stock price performance over the past 12 months lags the peer average by -49.6% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -525.2% higher than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Apps like Calm and Endel are exploring an expanding new universe of what’s becoming known as ‘functional sound’. Calm and others are doing it in the meditation and sleep space, while Endel, which has raised $7.5m, creates ‘functional music’ to enhance working or other activities. Now a new startup is launching what it calls ‘factional […]

Apps like Calm and Endel are exploring an expanding new universe of what’s becoming known as ‘functional sound’. Calm and others are doing it in the meditation and sleep space, while Endel, which has raised $7.5m, creates ‘functional music’ to enhance working or other activities. Now a new startup is launching what it calls ‘factional […]

Cal-Maine Foods shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 80 to 84.

Meditation app Calm is acquiring Ripple Health Group, a San-Francisco-based health care technology company. The terms of the deal were not disclosed. Calm says the acquisition will accelerate its mental healthcare ambitions. Following the acquisition, Ripple Health Group CEO David Ko will take on the role of Calm co-CEO, alongside Michael Acton Smith. Calm co-founder []

Meditation app Calm is acquiring Ripple Health Group, a San-Francisco-based health care technology company. The terms of the deal were not disclosed. Calm says the acquisition will accelerate its mental healthcare ambitions. Following the acquisition, Ripple Health Group CEO David Ko will take on the role of Calm co-CEO, alongside Michael Acton Smith. Calm co-founder []

David Ko, CEO and co-founder of Ripple Health Group, will join relaxation app Calm as co-CEO upon the company''s acquisition of Ripple.